The global clinical trial management services market was surpassed at USD 1.81 billion in 2021 and is expected to hit around USD 5.36 billion by 2030, growing at a CAGR of 12.82% from 2022 to 2030.
Report Summary
The global clinical trial management services market is anticipated to reflect considerable growth across the forecast period. The increasing trend of outsourcing clinical trial activities, the rise in research and development of advanced therapies, and the globalization of clinical trials are a few of the factors supporting the growth of the clinical trial management services market.
The COVID-19 pandemic had a significant impact on the clinical trial management services market. It also created an unexpected urgency for alternative solutions to clinical trial execution, limiting on-site monitoring visits. It prompted researchers to use remote clinical trial monitoring services and platforms to reduce the spread of the COVID-19 infection as well as to simultaneously function clinical research. For instance, according to the Florence survey in 2020, more than 60% of clinical study sites and clinical trial sponsors stated more than 50% acceptance of remote site monitoring solutions for clinical research.
The oncology segment is anticipated to hold the highest market share in the clinical trial management services market. High shares of the segment are majorly due to increasing cases of cancer across the globe. As per the American Cancer Society, in 2021, there is an estimated 1.9 million new cancer cases diagnosed in the U.S.
The clinical trial management services market in the Asia Pacific is expected to witness the most lucrative growth in the forecast period. High growth is anticipated owing to factors such as the cheap labor cost, presence of a diversity of patient pool, less cost associated with clinical trial activities compared to the western economies, awareness about clinical trial services, and the presence of major CROs in the region. For instance, 75% of the players in the region operate globally, whereas 25% are regional players.
Scope of The Report
Report Coverage | Details |
Market Size in 2021 | USD 1.81 billion |
Revenue Forecast by 2030 | USD 5.36 billion |
Growth rate from 2022 to 2030 | CAGR of 12.82% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Services, Industry, Indication, Region |
Companies Covered |
LabCorp, IQVIA, Syneous Health, Atlantic Research Group, ICON Plc, and a few others |
A few of the market players operating in the clinical trial management services market are LabCorp, IQVIA, Syneous Health, Atlantic Research Group, ICON Plc, and a few others. These companies are adopting various inorganic growth strategies such as mergers, collaborations, etc. For instance, in April 2021, Atlantic Research Group collaborated with Bio Products Laboratory (BPL) to provide clinical trial management services to BPL’s global new product development programs. Such initiatives support the growth of the company across the clinical trial management services market.
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Clinical Trial Management Services Market
5.1. COVID-19 Landscape: Clinical Trial Management Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Clinical Trial Management Services Market, By Services
8.1. Clinical Trial Management Services Market, by Services, 2022-2030
8.1.1 Clinical Trial Monitoring
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Regulatory Submissions
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Clinical Trial Data Management
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Medical Writing
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Site management & monitoring
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Clinical Trial Management Services Market, By Industry
9.1. Clinical Trial Management Services Market, by Industry, 2022-2030
9.1.1. Pharmaceuticals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Biopharmaceuticals
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Medical Devices
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Clinical Trial Management Services Market, By Indication
10.1. Clinical Trial Management Services Market, by Indication, 2022-2030
10.1.1. Immunology
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Hematology
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Oncology
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Dermatology
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Clinical Trial Management Services Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Services (2017-2030)
11.1.2. Market Revenue and Forecast, by Industry (2017-2030)
11.1.3. Market Revenue and Forecast, by Indication (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Services (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Industry (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Indication (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Services (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Industry (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Indication (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Services (2017-2030)
11.2.2. Market Revenue and Forecast, by Industry (2017-2030)
11.2.3. Market Revenue and Forecast, by Indication (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Services (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Industry (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Indication (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Services (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Industry (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Indication (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Services (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Industry (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Indication (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Services (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Industry (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Indication (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Services (2017-2030)
11.3.2. Market Revenue and Forecast, by Industry (2017-2030)
11.3.3. Market Revenue and Forecast, by Indication (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Services (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Industry (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Indication (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Services (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Industry (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Indication (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Services (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Industry (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Indication (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Services (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Industry (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Indication (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Services (2017-2030)
11.4.2. Market Revenue and Forecast, by Industry (2017-2030)
11.4.3. Market Revenue and Forecast, by Indication (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Services (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Industry (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Indication (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Services (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Industry (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Indication (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Services (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Industry (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Indication (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Services (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Industry (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Indication (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Services (2017-2030)
11.5.2. Market Revenue and Forecast, by Industry (2017-2030)
11.5.3. Market Revenue and Forecast, by Indication (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Services (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Industry (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Indication (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Services (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Industry (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Indication (2017-2030)
Chapter 12. Company Profiles
12.1. LabCorp
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. IQVIA
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Syneous Health
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Atlantic Research Group
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. ICON Plc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. others
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms